Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinma Xing Zhi Ke Pian for Acute Tracheobronchitis
CTR20254738Phase 3Active
- Sponsor
- Chengde Yanfeng Pharmaceutical
- Start
- Dec 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Jinma Xing Zhi Ke Pian in acute bronchitis, sponsored by Chengde Yanfeng Pharmaceutical. Started Dec 2025; status: active.
02
Drugs
Jinma Xing Zhi Ke Pian
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20254738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254738.